These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 27176150)
1. Nuclear EpICD expression and its role in hepatocellular carcinoma. Park SY; Bae JS; Cha EJ; Chu HH; Sohn JS; Moon WS Oncol Rep; 2016 Jul; 36(1):197-204. PubMed ID: 27176150 [TBL] [Abstract][Full Text] [Related]
2. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin. Jachin S; Bae JS; Sung JJ; Park HS; Jang KY; Chung MJ; Kim DG; Moon WS Int J Oncol; 2014 Aug; 45(2):691-8. PubMed ID: 24888903 [TBL] [Abstract][Full Text] [Related]
3. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes. Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133 [TBL] [Abstract][Full Text] [Related]
4. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis. Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668 [TBL] [Abstract][Full Text] [Related]
5. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma. Bae JS; Noh SJ; Jang KY; Park HS; Chung MJ; Park CK; Moon WS Int J Oncol; 2012 Dec; 41(6):2150-8. PubMed ID: 22993038 [TBL] [Abstract][Full Text] [Related]
6. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186 [TBL] [Abstract][Full Text] [Related]
7. Nuclear signalling by tumour-associated antigen EpCAM. Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway. Geng D; Zhao W; Feng Y; Liu J Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539 [TBL] [Abstract][Full Text] [Related]
9. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517 [TBL] [Abstract][Full Text] [Related]
10. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells. Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429 [TBL] [Abstract][Full Text] [Related]
11. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation. Lu WJ; Chua MS; Wei W; So SK Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
13. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
14. Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression. Panda SS; Lee CC; Geevimaan K; Chen KC; Yang SH; Shen CN; HuangFu WC; Wu HC J Biomed Sci; 2024 Jul; 31(1):72. PubMed ID: 39010070 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases. Felipe-Silva A; Wakamatsu A; Dos Santos Cirqueira C; Alves VA World J Gastroenterol; 2016 Jul; 22(27):6246-56. PubMed ID: 27468214 [TBL] [Abstract][Full Text] [Related]
16. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells. Yuan S; Lei S; Wu S Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592 [TBL] [Abstract][Full Text] [Related]
17. Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis. Lu C; He Y; Duan J; Yang Y; Zhong C; Zhang J; Liao W; Huang X; Zhu R; Li M Int J Oncol; 2017 Oct; 51(4):1135-1145. PubMed ID: 28902357 [TBL] [Abstract][Full Text] [Related]
18. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630 [TBL] [Abstract][Full Text] [Related]
19. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Yamashita T; Budhu A; Forgues M; Wang XW Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828 [TBL] [Abstract][Full Text] [Related]
20. Expression and significance of Wnt signaling components and their target genes in breast carcinoma. He Y; Liu Z; Qiao C; Xu M; Yu J; Li G Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]